$2.73
-0.1-3.53%
Last update: 3:32 PM
15 minutes delayed
Arcadia Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcadia Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $0.78 | $1.55 | -49.7 % |
Mar 2024 | 2024-05-09 | $-1.78 | $-2.21 | 19.5 % |
Dec 2023 | 2024-03-28 | $-2.10 | $-2.58 | 18.6 % |
Sep 2023 | 2023-11-09 | $-1.89 | $-3.19 | 40.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $1.31M | $920.00K | 42.0 % |
Mar 2024 | 2024-05-09 | $1.25M | $1.19M | 5.46 % |
Dec 2023 | 2024-03-28 | $1.17M | $1.75M | -33.1 % |
Sep 2023 | 2023-11-09 | $1.60M | $1.55M | 3.03 % |
Arcadia Biosciences (RKDA) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $0.78, which missed the estimate of $1.55.
The Actual Revenue was $1.3M, which beat the estimate of $920K.
Browse earnings estimates, EPS, and revenue on all stocks.